Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,278.70
-12.70 (-0.98%)
At close: Mar 23, 2026
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
11.98M INR
Profits / Employee
1.26M INR
Market Cap
742.67B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Mankind Pharma | 19,620 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 16,778 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
| Ajanta Pharma | 9,628 |
Aurobindo Pharma News
- 3 days ago - Aurobindo Pharma's subsidiary facility classified as 'Voluntary Action Indicated' by US FDA - Business Upturn
- 3 days ago - Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42% - Business Upturn
- 6 days ago - Aurobindo Pharma's Eugia Pharma unit classified as OAI by US FDA - Business Upturn
- 10 days ago - Aurobindo Pharma faces ₹77.61 crore GST demand and penalty - Business Upturn
- 11 days ago - Aurobindo Pharma's Unit-IV receives VAI classification from US FDA - Business Upturn
- 13 days ago - Top stocks to buy or sell: Stock market recommendations for today - check list - The Times of India
- 19 days ago - Aurobindo Pharma subsidiary launches Pomalidomide Capsules in US market, targets $3.3 billion opportunity - Business Upturn
- 21 days ago - Top stocks for trade today, March 2: Tata Motors, Hero MotoCorp, Zydus Lifesciences, Aurobindo Pharma, Vedanta and more - Business Upturn